ACTON, Mass.--(BUSINESS WIRE)--Cognoptix President and CEO Paul Hartung has been honored as “Emerging Medical Technologies Innovator of the Month” by Life Science Intelligence® (“LSI”). The accolade comes on the heels of clinical data presented recently at the ‘Clinical Trials on Alzheimer’s Disease’ (CTAD) scientific meeting related to the strong results of a multi-site clinical trial of the Cognoptix SAPPHIRE II eye test, which is designed to identify Alzheimer’s Disease (AD) patients via a beta-amyloid (Ab) signature in their eyes.
Help employers find you! Check out all the jobs and post your resume.
